Virus-like particles as nanovaccine candidates

Advances in Natural Sciences: Nanoscience and Nanotechnology

Volumn 4, Issue 1, 2013, Pages

  Guillen, G ^a   Aguilar, J C ^a   Duenas S ^a   Hermida, L ^a   Iglesias, E ^a   Penton, E ^a   Lobaina, Y ^a   Lopez, M ^a   Mussachio, A ^a   Falcon, V ^a   Alvarez, L ^a   Martinez, G ^a   Gil, L ^a   Valdes, I ^a   Izquierdo, A ^a   Lazo, L ^a   Marcos, E ^a   Guzman, G ^a   Muzio, V ^a   Herrera, L ^a  

^a CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Cuba)

Author keywords

HBV; HCV; Hepatitis; Human immunodeficiency virus; Th1; VLPs

Indexed keywords

IMMUNE SYSTEM; MAMMALS; PROTEINS; VACCINES; VIRUSES;

CELLULAR RESPONSE; HEPATITIS; HUMAN IMMUNODEFICIENCY VIRUS; MICROBIAL PROTEINS; PARENTERAL ADMINISTRATION; SYSTEMIC IMMUNITIES; VIRUS-LIKE PARTICLES; VLPS;

DISEASES;

EID: 84894119965     PISSN: None     EISSN: 20436262     Source Type: Journal    
DOI: 10.1088/2043-6262/4/1/015005     Document Type: Article

References (35)

1. Antonis A F et al 2006 Vaccine 24 5481
2. Young S L, Wilson M, Wilson S, Beagley K W, Ward V and Baird M A 2006 Vaccine 24 5406
3. Dell K, Koesters R, Linnebacher M, Klein C and Gissmann L 2006 Vaccine 24 2238
4. Kundig T M et al 2006 J. Allergy Clin. Immunol. 117 1470
5. Riedl P, Buschle M, Reimann J and Schirmbeck R 2002 Eur. J.Immunol. 32 1709
6. Lobaina Y, Palenzuela D, Pichardo D, Muzio V, Guillen G and Aguilar J C 2005 Mol. Immunol. 42 289
7. Riedl P, Stober D, Oehninger C, Melber K, Reimann J and Schirmbeck R 2002 J. Immunol. 168 4951
8. Lobaina Y, Palenzuela D, Pichardo D, Muzio V, Guillen G and Aguilar J C 2005 Mol. Immunol. 42 289
9. Pol S and Michel M L 2006 Expert Rev. Vaccines 5 707
10. Hui C K and Lau G K K 2005 Int. J. Med. Sci. 2 24
11. Iglesias E et al 2001 J. Biochem. Mol. Biol. Biophys. 5 109
12. Iglesias E, Garćia D, Carrazana Y, Aguilar J C, Śanchez A, Gorobaya L and Blanco A 2008 Curr. HIV Res. 6 452
13. Iglesias E, Garcia D, Marquez G, Prieto Y C, Sanchez J, Trimino L and Soria Y 2012 Int. Immunopharmacol 12 487
14. Iglesias E et al 2006 Immunol. Cell Biol. 84 174
15. Dueñnas-Carrera S, Morales J, Acosta-Rivero N, Lorenzo L J, Garćia C, Ramos T, Guerra I and Pẽna M 1999 Biotechnol. Apl. 16 226
16. Acosta-Rivero N et al 2009 Biol. Res. 42 41
17. Alvarez-Lajonchere L and Dueñas-Carrera S 2012 Int. Rev. Immunol. 31 223
18. Dueñas-Carrera S, Vina A, Martinez R, Alvarez-Lajonchere L, Alvarez-Obregon J C, Marante J, Perez A, Mosqueda O, Martinez G and Morales J 2004 Biotechnol. Appl. Biochem. 39 249
19. Acosta-Rivero N et al 2005 Am. J. Infect. Dis. 1 66
20. Alvarez-Lajonchere L and Due?nas-Carrera S 2009 Hum. Vaccine. 5 568
21. Martinez-Donato G et al 2010 Biotechnol. Appl. Biochem. 56 111
22. Chen Y, Maguire T and Marks R M 1996 J. Virol. 70 8765
23. Chin J F, Chu J J and Ng M L 2007 Microbes Infect. 9 1
24. Crill W D and Roehrig J T 2001 J. Virol. 75 7769
25. Hung J J, Hsieh M T, Young M J, Kao C L, King C C and Chang W 2004 J. Virol. 78378
26. Bernardo L et al 2008 Antiviral Res. 80 194
27. Hermida L et al 2006 Vaccine 24 3165
28. Hermida L et al 2004 Biotechnol. Appl. Biochem. 39 107
29. Hermida L, Rodriguez R, Lazo L, Silva R, Zulueta A, Chinea G, Lopez C, Guzman M G and Guillen G 2004 J. Virol. Methods 115 41
30. Valdes I et al 2009 Vaccine 27 995
31. Gil L et al 2012 J. Gen. Virol. 93 1204
32. Gil L et al 2009 Int. Immunol. 21 1175
33. Valdes I et al 2009 Virology 394 249
34. Izquierdo A, Valdes I, Gil L, Hermida L, Gutierrez S, Garcia A, Bernardo L, Pavon A, Guillen G and Guzman M G 2012 Antiviral. Res. 95 1
35. Valdes I, Gil L, Romero Y, Castro J, Puente P, Lazo L, Marcos E, Guzman M G, Guillen G and Hermida L 2011 Clin. Vaccine Immunol. 18 455